Tag: Eli Lilly

Today represents a pivotal moment for pharmaceutical giant Eli Lilly as the company prepares to release quarterly results that could ...

The pharmaceutical industry is experiencing a significant breakthrough, with Eli Lilly emerging as a frontrunner in the current market upswing. ...

Eli Lilly shares experienced a significant after-hours rally following confirmation of high-stakes pricing negotiations with the Trump administration. The pharmaceutical ...

Eli Lilly finds itself at a critical juncture, presenting investors with a complex narrative of ambitious expansion and unexpected research ...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an ...

The pharmaceutical landscape is witnessing a significant shift as Eli Lilly announces two major regulatory approvals across key international markets. ...

Eli Lilly finds itself at a crossroads, presenting investors with a complex picture of pharmaceutical development. The company is simultaneously ...

While Eli Lilly's diabetes medications continue to dominate headlines, the pharmaceutical giant has quietly achieved a significant regulatory victory that ...

Eli Lilly, the pharmaceutical giant, has unsettled investors with a surprising move: the sudden termination of a mid-stage clinical trial ...

Eli Lilly is making an unprecedented $6.5 billion wager on a single facility in Texas, dedicated to a drug that ...